AXE COMPUTE (AGPU) Sells Helomics Cancer Lab to DataMEDS in All-Stock Deal

Axe Compute has divested its AI cancer diagnostics subsidiary Helomics for DataMEDS stock, completing its shift to a pure-play GPU-as-a-Service business.

Share
Axe Compute operates GPU infrastructure for enterprises and AI developers.

Axe Compute (AGPU) has sold Helomics Corporation, its legacy artificial intelligence cancer diagnostics laboratory business, to DataMEDS AI (MEDS) in an all-stock transaction. The Pittsburgh-based company received common shares and common share equivalents of DataMEDS in exchange for its wholly-owned subsidiary, leaving it with an equity stake in the buyer rather than cash proceeds.